Explore All Access
Check if your research matches the topics covered in Blood Cells, Molecules, and Diseases?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Blood Cells, Molecules, and Diseases : Impact Factor & More
eISSN: 1096-0961pISSN: 1079-9796
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Blood Cells, Molecules, and Diseases Key Metrics
CiteScore 
5.4
Impact Factor
< 5
SNIP
0.98
Time to Accept
3
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months52%
4 to 6 months38%
7 to 9 months10%
Above 9 months0%
Did you find this useful?
Blood Cells, Molecules, and Diseases Journal Specifications
| Overview | |
| Publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1975 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Blood Cells, Molecules, and Diseases ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Blood Cells, Molecules, and Diseases
Editorial Board
- 1 Feb 2025
- Blood Cells, Molecules, and Diseases
Corrigendum to “Clinical utility of relative telomere length analysis in pediatric bone marrow failure” [Blood Cells Mol. Dis. 109 (2024) 102882]
- 7 Nov 2024
- Blood Cells, Molecules and Diseases
Marked microcytosis and increased transferrin saturation: Think about variants in SLC11A2 (DMT1)
- 2 Nov 2024
- Blood Cells, Molecules and Diseases
Editorial Board
- 1 Nov 2024
- Blood Cells, Molecules and Diseases
Identification of Nfel1a and Nfel3 as novel regulators for zebrafish thrombopoiesis
- 10 Oct 2024
- Blood Cells, Molecules and Diseases
Further biological characterization of small molecules UM171 and SR1: In vitro effects on three hematopoietic cell populations from human cord blood
- 18 Sep 2024
- Blood Cells, Molecules and Diseases
Editorial Board
- 1 Feb 2025
- Blood Cells, Molecules, and Diseases
Corrigendum to “Clinical utility of relative telomere length analysis in pediatric bone marrow failure” [Blood Cells Mol. Dis. 109 (2024) 102882]
- 7 Nov 2024
- Blood Cells, Molecules and Diseases
Marked microcytosis and increased transferrin saturation: Think about variants in SLC11A2 (DMT1)
- 2 Nov 2024
- Blood Cells, Molecules and Diseases
Editorial Board
- 1 Nov 2024
- Blood Cells, Molecules and Diseases
Identification of Nfel1a and Nfel3 as novel regulators for zebrafish thrombopoiesis
- 10 Oct 2024
- Blood Cells, Molecules and Diseases
Further biological characterization of small molecules UM171 and SR1: In vitro effects on three hematopoietic cell populations from human cord blood
- 18 Sep 2024
- Blood Cells, Molecules and Diseases
FAQs on Blood Cells, Molecules, and Diseases
How long has Blood Cells, Molecules, and Diseases been actively publishing? 
Blood Cells, Molecules, and Diseases has been in operation since 1975 till date.
What is the publishing frequency of Blood Cells, Molecules, and Diseases?
Blood Cells, Molecules, and Diseases published with a Bi-monthly frequency.
How many articles did Blood Cells, Molecules, and Diseases publish last year?
In 2023, Blood Cells, Molecules, and Diseases publsihed 43 articles.
What is the eISSN & pISSN for Blood Cells, Molecules, and Diseases?
For Blood Cells, Molecules, and Diseases, eISSN is 1096-0961 and pISSN is 1079-9796.
What is Citescore for Blood Cells, Molecules, and Diseases?
Citescore for Blood Cells, Molecules, and Diseases is 5.4.
What is SNIP score for Blood Cells, Molecules, and Diseases?
SNIP score for Blood Cells, Molecules, and Diseases is 0.98.
Who is the publisher of Blood Cells, Molecules, and Diseases?
ACADEMIC PRESS INC ELSEVIER SCIENCE is the publisher of Blood Cells, Molecules, and Diseases.
